Home > Insider Trading > Filing (0000899243-22-032861)

Filing Details

Accession Number:: 0000899243-22-032861
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-10-04 21:55:50
Reporting Period:: 2021-11-17

Accepted Time:: 2022-10-04 21:55:50
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1830214	Ginkgo Bioworks Holdings Inc.	DNA	Biological Products, (No Disgnostic Substances) (2836)	872652913

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1845677	R Jason Kelly	C/O Ginkgo Bioworks Holdings, Inc. 27 Drydock Avenue Boston MA 02210	See Remarks	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Acquisiton	2022-09-30	773,453	$0.00	773,453	No	4	M	Direct
Class A Common Stock	Acquisiton	2022-10-01	25,782,354	$0.00	26,555,807	No	4	M	Direct
Class A Common Stock	Disposition	2022-10-03	343,082	$3.12	26,212,725	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Price - 2
Class A Common Stock	Class B Common Stock	Disposition	2022-09-30	773,453	$0.00	$0.00
Class A Common Stock	Restricted Stock Units	Acquisiton	2021-11-17	25,782,354	$0.00	$0.00
Class A Common Stock	Restricted Stock Units	Disposition	2022-10-01	25,782,354	$0.00	$0.00

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
69,929,596	No	4	M	Direct
25,782,354	No	4	A	Direct
0	No	4	M	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Class A Common Stock	Class B Common Stock	$0.00			0	11,728,057	Indirect

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
	0	11,728,057	Indirect

Footnotes

Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock.
Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date.
Represents restricted stock units (the "RSUs") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the "Merger"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition was satisfied on October 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person.
Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligation to be funded by a "sell to cover" transaction.
Includes shares of Class B Common Stock that are subject to vesting conditions.